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Background: An increased awareness of patients’ and parents’ care preferences regarding foot care is desirable
from a clinical perspective as such information may be utilised to optimise care delivery. The aim of this study was
to examine parents’ preferences for, and valuations of foot care and foot-related outcomes in juvenile idiopathic
arthritis (JIA).
Methods: A discrete choice experiment (DCE) incorporating willingness-to-pay (WTP) questions was conducted by
surveying 42 parents of children with JIA who were enrolled in a randomised-controlled trial of multidisciplinary
foot care at a single UK paediatric rheumatology outpatients department. Attributes explored were: levels of pain;
mobility; ability to perform activities of daily living (ADL); waiting time; referral route; and footwear. The DCE was
administered at trial baseline. DCE data were analysed using a multinomial-logit-regression model to estimate
preferences and relative importance of attributes of foot care. A stated-preference WTP question was presented
to estimate parents’ monetary valuation of health and service improvements.
Results: Every attribute in the DCE was statistically significant (p < 0.01) except that of cost (p = 0.118), suggesting
that all attributes, except cost, have an impact on parents’ preferences for foot care for their child. The magnitudes of
the coefficients indicate that the strength of preference for each attribute was (in descending order): improved ability
to perform ADL, reductions in foot pain, improved mobility, improved ability to wear desired footwear, multidisciplinary
foot care route, and reduced waiting time. Parents’ estimated mean annual WTP for a multidisciplinary foot care service
was £1,119.05.
Conclusions: In terms of foot care service provision for children with JIA, parents appear to prefer improvements in
health outcomes over non-health outcomes and service process attributes. Cost was relatively less important than other
attributes suggesting that it does not appear to impact on parents’ preferences.
Keywords: Juvenile idiopathic arthritis, Foot, Discrete choice experiment, Health economics, PodiatryBackground
Foot impairments and disability persist in over 60% of
children who have juvenile idiopathic arthritis (JIA) des-
pite recent improvements in its medical management
[1,2]. The management of foot problems in JIA is com-
plex and involves combinations of medical and non-
medical therapies such as intra-articular corticosteroid
injections, foot orthoses and exercise regimens [2-5].* Correspondence: gordon.hendry@gcu.ac.uk
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stated.Regular visits to out-patients clinics are often necessary
and the burden of seeking care may be detrimental to
routine family life [6]. Moreover, paediatric patient ad-
herence to rehabilitative strategies is often poor and
non-compliance may limit the potential for benefits in
outcomes following therapy [7,8]. As such children with
JIA may respond poorly to intervention resulting in sus-
tained physical impairment, which may contribute nega-
tively to the economic impact of JIA [9,10].
Health care priorities and the preferences of health
care providers’ have been found to differ from those of
their patients, particularly patients with inflammatoryLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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parents’ care preferences is desirable from a clinical per-
spective as such information may be utilised to optimise
care delivery [12,13]. Qualitative perceptions of foot care
in JIA have been explored recently and several areas for
service improvement have been identified [14]. However
a limitation of qualitative research is that it does not per-
mit the ranking of preferences to provide information
regarding the importance of different aspects of care.
Parents’ preferences for drug treatments and health
outcomes in JIA have recently been explored, using a
technique known as a discrete choice experiment (DCE)
[15]. This study found that parents demonstrated stronger
preferences for treatments that reduced pain and improved
daily functioning, regardless of other considerations such
as associated side effects [15]. A DCE is a quantitative
technique for eliciting individual’s preferences for care [16].
A DCE questionnaire is comprised of choice sets of hypo-
thetical scenarios that are presented to study participants.
Each scenario describes different levels of the attributes
that characterise the intervention under evaluation [17].
The participants’ preferences are elicited by asking them to
state which scenario they prefer. DCEs are advantageous
by several means; they are useful in the context of clinical
trials, as they permit the gathering of rich preference infor-
mation concerning interventions that are exploratory/
experimental in nature [18,19]; they result in trade-off de-
cisions between health-related attributes which mimic
real-life decision-making situations [16,20]; and they can
be used within the framework of cost benefit analyses
(CBA) to estimate the value of individuals’ care prefer-
ences [21,22]. When cost is also considered as an attribute
alongside health-related outcomes, it is possible to con-
duct an indirect calculation of respondents’ willingness-
to-pay (WTP) for health care [23,24]. Willingness-to-pay
can be formally defined as the maximum amount of
money that an individual is prepared to part with in
order to receive a particular service [25]. The WTP con-
cept has been applied previously in JIA to assess health
care preferences of families of children with the disease
using a series of ‘bidding game’ questions [26], but it
may also be elicited through face to face interviews or
self-administered questionnaires.
To understand parents’ preferences, two elicitation
techniques were employed. A DCE provided insight as
to the relative importance of various attributes of foot
care. Additionally willingness-to-pay (WTP) values were
elicited to understand the monetary value parents place
on foot care for children/adolescents with JIA.
Methods
Participants and setting
The DCE here was embedded within an exploratory,
non-pharmacological randomised controlled trial (RCT)designed to investigate the effectiveness of a new
multidisciplinary foot care programme for children/
adolescents with JIA and disease-related foot problems
[27,28]. Study participants included parents/guardians of
children with JIA who met the inclusion criteria for the
RCT [27,28] which took place at the Royal Hospital for
Sick Children, Glasgow, UK between March 2009 and
March 2011. Briefly, children/adolescents with JIA were in-
cluded if they had a documented history of active foot dis-
ease. The DCE was administered at baseline of the RCT.
This RCT was registered with the International Standard
Randomised Controlled Trial Number (ISRCTN) register
(registration number ISRCTN49672274). The Glasgow
West Local Research Ethics Committee granted ethical ap-
proval for this study (Ref 06/S0703129). Written informed
consent was obtained from participants in accordance with
the Declaration of Helsinki.
DCE development
DCEs are comprised of choice sets of hypothetical
scenarios. Each scenario includes a set of attributes, at
varying levels, that characterise the intervention or health-
care service under evaluation [17]. For example; the attri-
bute “Waiting time for appointment” could be described
by the levels “1 month”, “3 months” or “6 months”. These
levels were agreed upon through consensus within the trial
steering committee based upon the local centre’s waiting
times for podiatry contact (3-6 months) which we deter-
mined through a pilot study [2]. The DCE presents a num-
ber of scenarios, where the attribute levels vary, and
participants are asked to state which scenario they prefer.
To identify the attributes that might be important, a litera-
ture review was first conducted [29]. This then informed
the design of a qualitative study of foot problems and foot
care in JIA, whereby the DCE attributes were derived from
the thematic analysis of the focus group and interview data
[14]. The attributes identified as important to JIA sufferers
were: pain, mobility impairment, reduced ability to perform
activities of daily living (ADL), footwear difficulties, and
poor referral pathways/delayed access to care (waiting) (see
Table 1) [14]. The route to podiatry care, particularly the
role of a multidisciplinary team, was also included as an at-
tribute as this was the intervention in the trial. Cost was in-
cluded to allow for an estimation of the marginal WTP of
each attribute. The lowest cost level was set at £80 by con-
sensus within the trial steering committee and was based
upon inflated costs of a single UK National Health Service
podiatry consultation [30], with £70 increments selected
for the remaining two cost levels (£150 and £220). Note
that a maximum of eight attributes were targeted a priori
to reduce cognitive burden [16,31,32].
The combination of attributes and levels, resulted in
large number of unique scenarios (six attributes with
three levels, one attribute with two levels = 1458 possible
Table 1 Description of final attributes and levels in the hypothetical scenarios
Attribute Description Variable names and levels
Pain relief Following treatment you will have the
following pain level
pain_0; no lower limb pain experienced whatsoever, pain_1;
A noticeable improvement in lower limb pain, pain_2; no
change in the levels of pain
Improvement in mobility Following treatment you will have the
following ability
mobility_0; Ability to move freely, mobility_1; a noticeable
improvement in the ability to move but some limitations,
mobility_2; No change in movement ability
Activities of daily living Following treatment you will have the
following ability
adl_0; Ability to take part in all usual everyday activities,
adl_1; Ability to take part in some usual everyday activities,
adl_2; No improvement in ability
Route to podiatry care (foot care) You will receive podiatry care via route_0; The appointment includes seeing the consultant,
the podiatrist and the physiotherapist in the same visit,
route_1; The consultant would decide whether to refer
you/your child to the podiatrist
Waiting time The waiting time for first podiatry contact will be Wait; 3months, 6months, 1 year.
Footwear Following treatment you will be able to wear footwear_0; ability to wear most types of shoes, footwear_1;
ability to wear limited types of shoes, footwear_2; ability to
wear specially made shoes only
Cost to you The total cost of the appointment to you will be Cost; £80, £150, £220.
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smaller fractional factorial design. The final attributes
and levels were formulated into 18 hypothetical scenar-
ios and were tested against optimum efficiency design
criteria using the SPExpt software package [33]. This
software calculates various potential fractional factorial
designs based upon the full factorial design, permitting
researchers to choose a feasible number of choice sce-
narios for a DCE questionnaire. The fractional design
was found to be 100% efficient, meeting the following
criteria; orthogonal with level balance (each attribute
level in the design occurs equally often, thus mimicking a
full factorial design), minimal overlap (attribute levels are
sufficiently varied in order to allow meaningful comparison
and trade-off, thus increasing the questionnaire’s ability for
eliciting the maximum amount of information possible
from each respondent), and uncorrelated main effects (the
attributes of the design as statistically independent of one
another and therefore the strength of preference elicited
from participants are not violated by aspects of the design)
[16,19]. Scenarios were paired using a fold-over technique
to create 18 pair-wise choices, where each scenario was
presented to respondents as “mirrored images” of the
alternative scenario (therefore maintaining 100% design
efficiency) [34]. Each choice set consisted of two alternative
hypothetical foot care programme scenarios (A or B). A
‘neither’ option was also included to offer to more closely
resemble a real world context (that is parents can choose
not to have their child treated) (see Figure 1) [16,35].
WTP elicitation
A payment scale (stated preference) WTP question, with
the addition of an open-ended question for large values,
was included to the start of the questionnaire. Respondentswere asked to indicate how much they would pay (0-£400,
in £20 and then £50 increments, or some higher value) for
an ‘ideal’ clinical scenario derived by the RCT steering
committee, which was effectively all the highest levels of
the DCE attributes (except cost).
Statistical analysis
DCE data were entered analysed using Stata Release 11
(StataCorp LP, Texas, USA) using a fixed effects multi-
nomial logit regression model based on McFadden’s ran-
dom utility model [36]. The ordinal variables ‘cost’ and
‘waiting time’ were re-coded as continuous variables.
Dummy coding was used to describe all remaining variables
[37]. Thus all ‘no change’ level selections for attributes;
pain, mobility, activities of daily living (ADL) and footwear
were excluded from the analysis as they represented the
status quo. Therefore the regression analysis was conducted
to calculate beta (β) coefficients for ‘maximum improve-
ment’ (for example; pain_0, ADL_0) or a ‘noticeable im-
provement’ (for example; pain_1, ADL_1) attribute levels.
The sign of the β coefficient (positive or negative) indicates
the direction of preference. For example, a positive β coeffi-
cient occurs where an increase in the attribute level results
in an increased likelihood that the study participant will
choose that scenario based on their preference for an in-
crease in the level of that attribute [38]. The magnitude of
the β coefficient represents the strength of preference for
choosing that particular attribute. The marginal WTP for
improvements in individual attributes were to be calculated
by dividing the coefficient of interest by the coefficient
attached to ‘cost’, pending the statistical significance of this
attribute following regression analysis [21].
Stated preference WTP values for the hypothetical
multidisciplinary foot clinic derived from the payment
Clinic A Clinic B
Pain relief A noticeable improvement in lower limb pain
No change in the levels of
pain experienced
Improvement in mobility Ability to move freely
without limitations
A noticeable improvement in 
the ability to move but some 
limitations
Activities of daily living
No improvement in ability to
take part in usual everyday 
activities (dependent on 
others)
Ability to take part in all
usual everyday activities with
no limitations (completely 
independent)
Route to podiatry care 
(foot care)
The hospital appointment 
includes seeing the 
consultant, the podiatrist and 
the physiotherapist in the 
same visit
The consultant would decide 
whether to refer you/your 
child to a separate 
appointment with the 
podiatrist
Waiting time for first 
podiatry contact Three months Six months
Footwear type 
Ability to wear specially 
made customised/ 
bespoke/orthopaedic shoes 
only
Ability to wear most types of 
shoes such as dress
shoes/football boots
Cost to you £150 £220
Which clinic would you prefer (tick one box only)?
Prefer Clinic A Prefer Clinic B Neither
Figure 1 An extract choice set from the final DCE questionnaire. Eighteen of these choice sets were presented in the final questionnaire.
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average annual WTP for the hypothetical ‘ideal’ scenario
was calculated by multiplying the mean WTP estimate
by the mean number of clinical consultations per partici-
pant over the 12 months of the RCT. As such, the WTP
for a single clinical visit was multiplied by 5 (there were
5 clinical visits over the 12months of the RCT) to provide
an estimate of annual WTP. This health care resource use/
consumption data was collected retrospectively from
patients’ case notes after final follow up in the main RCT
(12 months from baseline).
Results
Respondents
Forty-two parents (38 female: 4 male) of 42 children (29
female: 13 male) with a mean (SD) age of 10.1 (3.81) re-
turned completed questionnaires from the 44 issued at trialbaseline, giving a response rate of 95% (see Table 2 for par-
ent RCT participant baseline characteristics). Two female
parent participants did not complete the questionnaire
(one parent refused to participate stating the distressing
nature of choosing between health states for their child as
the primary reason, one parent did not return their com-
pleted questionnaire). As each participant (n = 42) was pro-
vided with 18 hypothetical choice set scenarios in the
DCE, there is a total of 756 observations. For 141 (18.7%)
of these, respondents selected the ‘neither’ option. There-
fore, there were 615 (81.3%) of 756 observations where re-
spondents indicated a preference for scenarios A or B.
Relative importance of attributes
The frequency of observations for the majority of each
attribute levels suggests that the DCE and regression
model appeared to be internally valid; respondents prefer
Table 2 Baseline characteristics of the parent RCT [23]
participants (n = 42 children/adolescents)
Characteristic Value
Demographics
Age (yrs)* 10.1 (3.8)
Male/female (n) 13/29
Body mass index* 19.1
SDS BMI percentiles* 64.5 (0.3)
Disease duration (months)* 46.9 (35.9)
Pharmacological management
Analgesics: n (%) 5 (12)
NSAIDs: n (%) 5 (12)
Methotrexate: n (%) 32 (76)
Etanercept: n (%) 12 (29)
Sulphasalazine: n (%) 1 (2)
Rituximab: n (%) 1 (2)
Combination methotrexate & etanercept: n (%) 10 (24)
Disease subtypes
Persistent oligo: n (%) 10 (24)
Extended oligo: n (%) 9 (21)
Poly-: n (%) 15 (36)
Poly+: n (%) 2 (5)
PsA: n (%) 3 (7)
ERA: n (%) 2 (5)
Systemic: n (%) 0 (0)
Undifferentiated: n (%) 1 (2)
*Mean (standard deviation); n, number of participants; SDS, standardised
deviation score British 1990 growth reference (UK 90); NSAID, non-steroidal
anti-inflammatory drugs; Poly -, polyarthritis rheumatoid factor negative; poly+,
polyarthritis rheumatoid factor positive; PsA, psoriatic arthritis; ERA, enthesitis
related arthritis.
Table 3 Frequencies (absolute and cumulative %) of
observations for each attribute level
Attribute Levels* Frequency
(abs)
Frequency
(%)
Cum frequency
(%)
Pain pain_0 250 40.65 40.65
pain_1 219 35.61 76.26
pain_2 146 23.74 100.00
Mobility mobility_0 246 40.00 40.00
mobility_1 222 36.10 76.10
mobility_2 147 23.90 100.00
ADL adl_0 292 47.48 47.48
adl_1 187 30.41 77.89
adl_2 136 22.11 100.00
Route route_0 345 56.10 56.10
route_1 270 43.90 100.00
Wait 3 months 229 37.24 37.24
6 months 189 30.73 67.97
12 months 197 32.03 100.00
Footwear footwear_0 250 40.65 40.65
footwear_1 206 33.50 74.15
footwear_2 159 25.85 100.00
Cost £80 185 30.08 30.08
£150 195 31.71 61.79
£220 235 38.21 100.00
*pain_0; no lower limb pain; pain_1 a noticeable improvement, pain_2; no
change, mobility_0; ability to move freely, mobility_1; a noticeable
improvement; mobility_2; no change; adl_0 ability to take part in all activities,
adl_1; ability to take part in some activities, adl_2 no improvement, route_0;
appointment including the consultant, podiatrist and physio, route_1;
consultant’s decision to refer, waiting time; 3months, 6months, 12months,
footwear_0; ability to wear most shoes, footwear_1; ability to wear limited
shoes, footwear_2; custom shoes only, cost; £80, £150, £220.
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(see Table 3). Although the observations for ‘wait’ appeared
to be contrary to a priori expectations, as some respon-
dents appeared to choose a longer waiting time. In 37.2%
of observations respondents chose a scenario with a 3
month waiting time, while in 32% of observations respon-
dents chose a scenario with a 12 months waiting time ver-
sus 30.7% of observations where respondents chose a
scenario with a 6 months waiting time. Similarly, observa-
tions for ‘cost’ appeared to be contrary to a priori expecta-
tions as respondents tended to choose a scenario with a
greater cost (in 30.08% of observations respondents chose
£80, in 31.71% of observations respondents chose a sce-
nario with £150, and in 38.21% of observations respon-
dents chose a scenario with £220.
Preferences for attributes of care
Each attribute’s regression coefficients (β) were statistically
significant (p < 0.01) except cost (β = 0.002, p = 0.118),suggesting that all attributes, except cost, were independ-
ently associated with parent respondents’ preferences
(see Table 4). For the entire cohort of respondents, the
magnitudes of the coefficients indicate that the order of
importance (that is strength of preference) for each
attribute level was: ‘ability to take part in all activities’
(β = 1.29), ‘no lower limb pain’ (β = 0.94), ‘ability to move
freely’ (β = 0.89,), ‘ability to wear most shoes’ (β = 0.83), ‘a
noticeable improvement in pain’ (β = 0.75), ‘a notice-
able improvement in mobility’ (β = 0.69), ‘ability to take
part in some activities’ (β = 0.58), ‘ability to wear lim-
ited shoes’ (β = 0.48), ‘appointment including consult-
ant, podiatrist and physio’ (β = 0.31), and ‘waiting time’
(β = -0.04) (see Table 4 and Figure 2). The sign of the
β values suggests that parents preferred: a reduction in
pain, improvements in mobility, the ability to perform
ADL, and the ability to wear desired footwear; referral to
a multi-disciplinary foot-care programme; and a reduced
waiting time.
Table 4 Results from the fixed effect multinomial logit
regression
Attributes* β coefficient SE 95% CI p-value
pain_0 0.94 0.15 (0.65, 1.24) p < 0.01
pain_1 0.75 0.15 (0.47, 1.04 p < 0.01
mobility_0 0.89 0.15 (0.61, 1.18) p < 0.01
mobility_1 0.69 0.14 (0.41, 0.98) p < 0.01
adl_0 1.29 0.14 (1.01, 1.58) p < 0.01
adl_1 0.58 0.15 (0.29, 0.86) p < 0.01
Route 0.31 0.09 (0.12, 0.5) p < 0.01
Wait** −0.04 0.02 (-0.07, -0.008) p = 0.013
footwear_0 0.83 0.14 (0.54, 1.11) p < 0.01
footwear_1 0.48 0.14 (0.19, 0.76) p < 0.01
Cost** 0.002 0.001 (-0.0005, 0.004) p = 0.138 NS
*pain_0; no lower limb pain; pain_1 a noticeable improvement, mobility_0;
ability to move freely, mobility_1; a noticeable improvement; adl_0 ability to
take part in all activities, adl_1; ability to take part in some activities, route;
appointment including the consultant, podiatrist and physio, footwear_0;
ability to wear most shoes, footwear_1; ability to wear limited shoes.
**continuous variables.
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The statistical non-significance of the cost attribute
meant that it was inappropriate to estimate indirect
WTP values using the DCE. From the stated preference
WTP question the mean (SD) WTP for the hypothetical
clinical scenario was £223.81 (£144.37), and the median
(range) was £200.00 (£0-£400). Nine respondents (21%)
indicated that they would pay up to £80, 15 respondents
(36%) indicated that they would pay between £100 and
up to and including £200, 18 respondents (43%) indi-
cated that they would pay £220 or more. Of the latter 18
respondents, 7 stated that they would pay more thanComparison of beta coeff
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Figure 2 Error bars showing beta coefficients and associated 95% con
regression analysis.£400 for the hypothetical clinical scenario. There were
five clinical trial appointments per participant over the
12 months of the RCT, therefore parents’ mean annual
WTP for the intervention was estimated as £1,119.05.
Two participants stated that they ‘could not afford to
pay’ for the hypothetical clinic, but if they ‘could pay
they probably would’. Two participants stated that they
‘would object to paying any extra on top of tax’ for the
hypothetical clinic. Six participants in total stated that
they could not put a limit on what they would pay be-
cause they would ‘pay anything’. One participant stated
that they would pay £500 for the ‘ideal’ clinical scenario.
From the DCE observations (n = 615), 30% of re-
sponses indicated a preference for a cost of £80, 32% for
a cost of £150, and 38% for £220. Aggregated scores from
the stated preference WTP question responses (n = 42) in-
dicated that 21% of respondents were prepared to incur a
cost of up to £80, 36% for between £100-£200, and 43%
for £220 or more for the hypothetical clinical scenario
(Figure 3). The stated preference WTP responses are
relatively consistent with the DCE observations suggests
that the DCE model was internally valid, as respondents
appeared to be WTP a higher cost for improvements in
foot health and process attributes regardless of elicit-
ation method.
Parents’ WTP for 12 months of the experimental
intervention was estimated at £1,119.05, derived from
the stated preference WTP question and hypothetical
‘ideal’ scenario. This was far lower than the estimated
mean annual cost of the experimental intervention that
was subject to investigation via the RCT which was
£5,025.70. Estimated costs of the intervention exceeded
parents’ perceived valuation of benefits of the best pos-
sible outcome.icients (95% CI) from 
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This study resulted reports on the development and de-
sign of a DCE and stated preference WTP questionnaire
used to elicit parental preferences for foot care for chil-
dren with JIA. According to the British Society for
Paediatric and Adolescent Rheumatology (BSPAR) and
Arthritis and Musculoskeletal Alliance (ARMA) stan-
dards of care for JIA guidelines, all children and adoles-
cents with JIA should have access to foot care [39,40].
At present very little is known about the provision of
foot care in JIA [2,14], and there is little evidence on
parents’ views and opinions of foot care, particularly
from those who have had no experience of foot care ser-
vices. As such this study adds rich and robust informa-
tion regarding preferences for foot care in JIA which
could be utilised to improve foot care services.
The results suggest that parent respondents appeared
to prefer improvements in health outcomes over non-
health outcomes and podiatry service process attributes.
This is a common but not an exclusive finding in DCE
research. A recent DCE found that parents of children
with JIA demonstrated strong preferences for interven-
tions that reduced pain and improved function [15]. In
contrast, adult rheumatology outpatients ranked non-
health attributes as more important relative to pain
levels [41]. The results from this study may represent
parents’ desires for their children to have more normal
lives, but further research is required to substantiate this
claim.
Maximal improvements in the ADL attribute appeared
to be the most important attribute to parents. Arguably
this finding is somewhat surprising, as it appears to have
a greater influence over parents’ choices relative to im-
provements in pain relief. Pain relief has been cited an
important aspect of care by parents, patients, paediatricrheumatologists and allied health professionals in previ-
ous studies [14,15]. Overall, maximal improvements in
the ADL attribute, together with ‘pain’, ‘mobility’ and
‘ability to wear desired footwear’ attributes were consid-
ered to be most important to the parent respondents.
However, it is possible that children’s experiences of JIA
may lead to different preferences for care that are centred
on their sense of self and social identity [42]. For example,
in this study parents appeared to prefer the options for
improvements in their child’s health, however qualitative
research suggests children with JIA may not want to be
labelled as sick or disabled and therefore may have entirely
different preferences for their own care [42].
The parental preference data derived from this DCE
may be useful for informing aspects of service provision
for children who have JIA related foot problems. Previ-
ous research suggests paediatric rheumatologists and
health professionals require more information about
which foot symptoms are in need of urgent attention
[14]. Parental preferences for the key outcomes identi-
fied in this study could be incorporated into a new
patient-reported outcome measure designed to inform
urgency for referral to foot care services. Alternatively,
the use of an existing tool known as the Juvenile Arthritis
Foot Disability Index [43] which includes items related to
these key outcomes, could be re-designed to incorporate
foot disability severity thresholds and guide referrals for
foot care.
A lack of suitable footwear choices for children with
JIA-related foot disease has been previously identified as
problematic [14]. Parents appeared to rank the ability of
their child to wear desired footwear as important, con-
firming previous findings. In contrast to a growing body
of research in adult RA, [44,45] the impact of limited
footwear choices as a result of disease-related foot prob-
lems have not been investigated in JIA. This is surprising
as foot deformities such as valgus hindfoot and clawed
lesser toes appear to be common [2,46,47].
Of the process attributes, ‘route to care’ involving an
appointment with the paediatric rheumatologist, podia-
trist and physiotherapist in the same visit was considered
to some importance, and was more important than wait-
ing time and cost. This is a novel finding as it demon-
strates that parents may gain utility from the prospect of
their child receiving multi-disciplinary foot care, as op-
posed to a separate doctor’s referral for separate foot
care. However, this could be the result of the Hawthorne
effect where respondents have modified their decision
making process as a response to being enrolled in the main
‘open label’ RCT of multidisciplinary foot care [23,48].
Unlike the majority of DCEs, the cost attribute did not
reach statistical significance in the regression analysis.
This implies that parents’ preferences were not influenced
by having to pay more. The stated preference (payment
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were willing to pay £224, with six parents stating that they
would pay anything to improve their child’s health out-
comes. It is important to acknowledge that in a health care
system where care is free at the point of access (as is the
case in the NHS); it is difficult to obtain accurate informa-
tion to inform the levels of cost in a DCE. It is possible that
the values of £80, £150 and £220 were too low. In addition,
household income data was not available and as such
WTP figures were not expressed as a percentage of in-
come, which would have been a more useful representation
of parents’ WTP. Future research perhaps should seek to
replicate this DCE with higher values as guided by the
stated preference WTP results, or preferably as a per-
centage of household income. Only then would it be
possible to ascertain if a parent views their child’s health
as ‘priceless’.
When completing DCEs, respondents are required to
process large amounts of information resulting in signifi-
cant cognitive burden [49]. As such, respondents may
make attempts to reduce their cognitive burden through
lexicographic and heuristic strategies [26,50,51]. Lexico-
graphic preferences are where a respondent ranks attri-
butes in order of importance and bases their decision on
the highest priority attributes [49]. While heuristics are
where respondents employ simple ‘rules of thumb’ to
reduce the cognitive burden, such as limiting their re-
sponses to trade-offs between one or two attributes per
scenario [50,51]. Furthermore, the sequential ordering of
attributes in the DCE scenarios can have an effect on
the relative utility weights associated with those attri-
butes [52]. The effects of sequential ordering on utility
weights were not formally explored in this study; how-
ever it is interesting to note that the β coefficients of the
first three attributes listed in the DCE scenarios have the
greatest magnitude. Whereas, ‘cost’ was the lowermost
attribute in the DCE scenarios and had the smallest β
coefficient magnitude.
The sample size of the study must also be considered
when interpreting its results. The sample size was dic-
tated by the number of participants enrolled in the main
RCT [27]. It should also be noted this DCE was per-
formed in a group of parents whose children were en-
rolled in an exploratory RCT of multidisciplinary foot
care [27] and therefore there may be a threat to the ex-
ternal validity of its findings due to cross-purpose, con-
venience and Hawthorne effects. Nevertheless, the DCE
was administered at baseline prior to exposure to the
foot care intervention, and the inclusion criteria of the
parent study [27] (see Participants and Setting) appear
directly relevant to the present study which aimed to
elicit foot care preference information of parents of chil-
dren with JIA who have foot problems. Of those parents
who participated, only 42 fully completed the DCEquestionnaire. According to the literature previous DCEs
have recruited a minimum of 40 respondents to success-
fully establish sufficient models [53]. However with the in-
clusion of the ‘neither’ option and the high frequency of
non-responses, it is likely that a larger sample size may
have improved both the richness and robustness of the re-
sults. It should be noted that the sample size was driven by
the RCT sample which, while not directly relevant to the
statistical modelling in this study was appropriately pow-
ered for the trial endpoint.
An unresolved issue in health economics is the appli-
cation of WTP elicitation methods where respondents
receive care which is free at the point of contact in a
publicly funded healthcare system such as the NHS in
the UK. As such some respondents may interpret the
WTP value as the cost incurred by the health service to
deliver that service. Alternatively respondents may inter-
pret the cost attribute as one that can be ignored as cost
is not incurred by them directly [21]. It is possible that
either of these points may have contributed to the non-
significance of the cost attribute in this study. Lastly, it
should be noted that household income data was not
measured as part of this study so as not to overburden
respondents who were required to complete many ques-
tionnaires during the main RCT. This restricted our
ability to identify whether or not income influenced re-
spondents choice, particularly concerning cost. As such,
the results relating to cost could be potentially mislead-
ing, and future DCEs including a cost attribute should
include cost as an appropriately determined percentage
of household income.
Conclusions
This study is the first study to employ a DCE to elicit
preferences from parents of children with JIA regarding
foot care. The health attributes ‘ADL’, ‘pain’, ‘mobility’, and
‘footwear’, as well as the non-health attributes ‘waiting
time’ and ‘route to care’ should be considered by policy
makers and health professionals involved in foot care
services/care delivery. This study has uniquely highlighted
the importance of non-health attributes of foot care to par-
ents of children with JIA. Furthermore, it has demon-
strated that parents appear to value, and gain utility from
the idea of the potential benefits of foot care for their chil-
dren. In a constrained economy with competing resources,
this exploratory study suggests that decision makers might
wish to favour interventions that improve ADL, pain and
mobility, as these are valued most highly by parents.
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